FindMyRecallSubscribe
Class I: serious health riskOngoing

Hikma Pharmaceuticals Acetaminophen Injection Recall

Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For I…

Hikma Pharmaceuticals USA Inc. · Cherry Hill, NJ

Risk level
Class I
Reported by FDA
Aug 28, 2024
Recall ID
D-0635-2024
Check your lot numberHow we source this data

Summary

Hikma Pharmaceuticals recalled Acetaminophen Injection starting Jul 8, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0635-2024 on Aug 28, 2024. Reason: Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL). Status: Ongoing.

Why it was recalled

Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)

Product description

Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous Use Only, Rx Only, Manufactured by: Hikma Farmaceutica (Portugal), SA, distributed by Hikma Pharmaceuticals USA Inc Berkeley Heights, NJ NDC 0143-9386-01

Lot numbers, UPCs & expiration codes

Lot #24070381; Exp. 09/30/2025

Where it was sold

OH and PR

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0635-2024
Classification
Class I
Status
Ongoing
Recall initiated
Jul 8, 2024
FDA report date
Aug 28, 2024
Quantity
31,400 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Hikma Pharmaceuticals USA Inc.

Original FDA data

Every field from FDA enforcement report D-0635-2024, exactly as published.

Show all FDA fields
City
Cherry Hill
State
NJ
Status
Ongoing
Country
United States
Event ID
94934
Address
2 Esterbrook Ln
Code information
Lot #24070381; Exp. 09/30/2025
Postal code
08003-4002
Report date
Aug 28, 2024
Product type
Drugs
Recall number
D-0635-2024
Classification
Class I
Recalling firm
Hikma Pharmaceuticals USA Inc.
Product quantity
31,400 bags
Reason for recall
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous Use Only, Rx Only, Manufactured by: Hikma Farmaceutica (Portugal), SA, distributed by Hikma Pharmaceuticals USA Inc Berkeley Heights, NJ NDC 0143-9386-01
Distribution pattern
OH and PR
Recall initiation date
Jul 8, 2024
Initial firm notification
Letter
Center classification date
Aug 16, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0635-2024, published Aug 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls